We are live on ! Find out more
CO

Global Cord Blood Corporation
CO

Delisted

CO was delisted on the 23rd of September, 2022.

Back to rankings

1 hedge funds and large institutions have $51.5K invested in Global Cord Blood Corporation in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% less capital invested

Capital invested by funds: $71.4K → $51.5K (-$19.9K)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$9.13K
2
OA
Operose Advisors
Wisconsin
-$270
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$51.5K -$9.13K -7,937 -15%
OA
2
Operose Advisors
Wisconsin
– -$270 -200 Closed

CO Hedge Fund Activity: Q2 2024 in Review

1 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2024, worth a combined $51.5K — down 28% from $71.4K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CO and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was RhumbLine Advisers, cutting an estimated $9.13K.

  • 1 institutional investor held Global Cord Blood Corporation (CO) as of Q2 2024, down from 2 in Q1 2024.
  • Funds reported $51.5K of Global Cord Blood Corporation stock for Q2 2024, down 28% quarter-over-quarter.
  • 0 funds opened new Global Cord Blood Corporation positions in Q2 2024 and 1 closed out, a net change of -1 holder.
  • The largest Global Cord Blood Corporation seller in Q2 2024 was RhumbLine Advisers, an estimated $9.13K sold.

Based on aggregated 13F filings for Q2 2024.